Open Market Insiders Trades - Buys only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
JAKK
|
Lawrence I Rosen
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 12,150 Added 1.59% |
$86,143
$7.09 p/Share
|
Apr 08
2021 |
|
RDW
|
Crescent Park Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 63,927 Added 2.45% |
$685,297
$10.72 p/Share
|
Apr 07
2021 |
|
SREV
|
Edenbrook Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 54,140 Added 0.14% |
$75,796
$1.4 p/Share
|
Apr 07
2021 |
|
HSON
|
Jeffrey E. Eberwein
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 500 Added 0.4% |
$8,410
$16.82 p/Share
|
Apr 07
2021 |
|
FMBM
|
Mark Christopher Hanna |
BUY
Open market or private purchase
|
Direct | 36 Added 0.39% |
$990
$27.5 p/Share
|
Apr 07
2021 |
|
FMBM
|
Stephanie E Shillingburg |
BUY
Open market or private purchase
|
Direct | 10 Added 0.53% |
$275
$27.5 p/Share
|
Apr 07
2021 |
|
FMBM
|
Carrie A Comer |
BUY
Open market or private purchase
|
Direct | 1 Added 0.09% |
$28
$27.5 p/Share
|
Apr 07
2021 |
|
TSI
|
Laird Landmann
PORTFOLIO MANAGER |
BUY
Open market or private purchase
|
Direct | 46,582 Added 7.59% |
$264,120
$5.67 p/Share
|
Apr 07
2021 |
|
IGXT
|
Andre Godin
President and CFO |
BUY
Open market or private purchase
|
Direct | 20,000 Added 9.08% |
$8,800
$0.44 p/Share
|
Apr 07
2021 |
|
JMP
|
Wedbush Securities Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 136 Added 0.01% |
$884
$6.5 p/Share
|
Apr 07
2021 |
|
JMP
|
Wedbush Securities Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 136 Added 0.01% |
$884
$6.5 p/Share
|
Apr 07
2021 |
|
LOV
|
Osmium Partners, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 5,353 Added 0.39% |
$40,362
$7.54 p/Share
|
Apr 07
2021 |
|
WMPN
|
Alan B Turner
EVP and CLO |
BUY
Open market or private purchase
|
Direct | 9,000 Added 47.37% |
$102,510
$11.39 p/Share
|
Apr 07
2021 |
|
CMTV
|
Fredric Oeschger |
BUY
Open market or private purchase
|
Direct | 115,750 Added 50.0% |
$2,257,125
$19.5 p/Share
|
Apr 07
2021 |
|
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 27 Added 0.27% |
$43,539
$1612.57 p/Share
|
Apr 07
2021 |
|
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 3 Added 0.26% |
$4,838
$1612.57 p/Share
|
Apr 07
2021 |
|
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.18% |
$1,721
$2.55 p/Share
|
Apr 07
2021 |
|
JRO
|
Scott C. Caraher |
BUY
Open market or private purchase
|
Direct | 5,000 Added 10.72% |
$47,900
$9.58 p/Share
|
Apr 07
2021 |
|
PRCH
|
Javier Saade
Director |
BUY
Open market or private purchase
|
Direct | 500 Added 50.0% |
$8,800
$17.6 p/Share
|
Apr 07
2021 |
|
AXR
|
Edward B Cloues Ii
Director |
BUY
Open market or private purchase
|
Direct | 35 Added 0.23% |
$350
$10.0 p/Share
|
Apr 07
2021 |
|
SNSE
|
James Peyer |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 0.04% |
$28,000
$14.0 p/Share
|
Apr 07
2021 |
|
SNSE
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct | 2,000 Added 0.04% |
$28,000
$14.0 p/Share
|
Apr 07
2021 |
|
WINT
|
Eric Curtis
SVP & COO |
BUY
Open market or private purchase
|
Direct | 791 Added 37.99% |
$1,993
$2.52 p/Share
|
Apr 07
2021 |
|
PFHO
|
Tom Kubota
CEO & President |
BUY
Open market or private purchase
|
Direct | 2,000 Added 0.03% |
$2,240
$1.12 p/Share
|
Apr 07
2021 |
|
HQI
|
Kathleen M Shanahan |
BUY
Open market or private purchase
|
Direct | 500 Added 1.42% |
$9,595
$19.19 p/Share
|
Apr 07
2021 |
|
FRAF
|
Mark R Hollar
EVP, CFO |
BUY
Open market or private purchase
|
Direct | 3 Added 0.05% |
$94
$31.18 p/Share
|
Apr 07
2021 |
|
MACK
|
Gary L Crocker |
BUY
Open market or private purchase
|
Indirect | 2,127 Added 6.31% |
$13,166
$6.19 p/Share
|
Apr 07
2021 |
|
MTEM
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct | 200,000 Added 2.29% |
$1,648,000
$8.24 p/Share
|
Apr 07
2021 |
|
IGXT
|
Tommy Kenny
SVP IP Legal Affairs Subsid |
BUY
Open market or private purchase
|
Direct | 20,000 Added 18.87% |
$9,000
$0.45 p/Share
|
Apr 07
2021 |
|
DSE
|
Css LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 15 Added 0.0% |
$111
$7.4 p/Share
|
Apr 07
2021 |
|
TYME
|
Jan M Van Tornout
Acting Chief Medical Officer |
BUY
Open market or private purchase
|
Direct | 247 Added 12.01% |
$420
$1.7 p/Share
|
Apr 07
2021 |
|
CMTV
|
Fredric Oeschger |
BUY
Open market or private purchase
|
Direct | 1,075 Added 0.92% |
$20,962
$19.5 p/Share
|
Apr 07
2021 |
|
COMP
|
Robert L. Reffkin
Chairman and CEO |
BUY
Open market or private purchase
|
Indirect | 411,111 Added 4.56% |
$7,399,998
$18.0 p/Share
|
Apr 06
2021 |
|
JOAN
|
Wade D Miquelon
President & CEO |
BUY
Open market or private purchase
|
Direct | 47,550 Added 31.68% |
$540,168
$11.36 p/Share
|
Apr 06
2021 |
|
TSI
|
Laird Landmann
PORTFOLIO MANAGER |
BUY
Open market or private purchase
|
Direct | 87,525 Added 14.4% |
$496,267
$5.67 p/Share
|
Apr 06
2021 |
|
AXR
|
Edward B Cloues Ii
Director |
BUY
Open market or private purchase
|
Direct | 2,000 Added 10.76% |
$20,000
$10.0 p/Share
|
Apr 06
2021 |
|
RDW
|
Crescent Park Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 36,100 Added 1.43% |
$373,274
$10.34 p/Share
|
Apr 06
2021 |
|
PHX
|
Edenbrook Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 933 Added 0.03% |
$2,612
$2.8 p/Share
|
Apr 06
2021 |
|
GEF-B
|
Gary R Martz
EVP & General Counsel |
BUY
Open market or private purchase
|
Direct | 7,000 Added 46.36% |
$414,260
$59.18 p/Share
|
Apr 06
2021 |
|
CDXS
|
Patrick Y Yang
Director |
BUY
Open market or private sale
|
Direct | 10,000 Added 11.95% |
$251,500
$25.15 p/Share
|
Apr 06
2021 |
|
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 27 Added 0.27% |
$43,078
$1595.49 p/Share
|
Apr 06
2021 |
|
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 3 Added 0.26% |
$4,786
$1595.49 p/Share
|
Apr 06
2021 |
|
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.18% |
$1,775
$2.63 p/Share
|
Apr 06
2021 |
|
PTA
|
Daphne L Richards
Director |
BUY
Open market or private purchase
|
Direct | 40 Added 0.98% |
$998
$24.94 p/Share
|
Apr 06
2021 |
|
AMTI
|
David Lamond
Director |
BUY
Open market or private purchase
|
Indirect | 25,000 Added 2.41% |
$1,050,000
$42.0 p/Share
|
Apr 06
2021 |
|
VIRI
|
Gregory Scott Duncan
CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct | 382 Added 1.88% |
$2,430
$6.36 p/Share
|
Apr 06
2021 |
|
WINT
|
Craig Fraser
President and CEO |
BUY
Open market or private purchase
|
Direct | 500 Added 1.74% |
$1,285
$2.57 p/Share
|
Apr 06
2021 |
|
JMP
|
Wedbush Securities Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 292 Added 0.01% |
$1,810
$6.2 p/Share
|
Apr 06
2021 |
|
JMP
|
Wedbush Securities Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 292 Added 0.01% |
$1,810
$6.2 p/Share
|
Apr 06
2021 |
|
LOV
|
Osmium Partners, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 3,000 Added 0.22% |
$22,590
$7.53 p/Share
|
Apr 06
2021 |